Harrer Judith U, Morschel Ralf, Mull Michael, Kosinski Christoph M
Neurological Clinic, RWTH Aachen University Hospital, Pauwelsstr. 30, 52074, Aachen, Germany.
J Neurol. 2008 Sep;255(9):1309-14. doi: 10.1007/s00415-008-0875-x. Epub 2008 Sep 24.
Carotid endarterectomy (CEA) is the gold-standard procedure for the majority of patients with high-grade symptomatic internal carotid artery stenosis and also for specified high-grade asymptomatic stenoses; however, a proportion of patients are treated with carotid endovascular therapy. We aimed to document medium-term clinical and neurosonographical outcome after carotid artery stenting (CAS).
53 patients (mean age: 65 +/- 8 years) with high-grade (> or = 70 % by means of duplex sonography) carotid artery stenosis were enrolled into the study. Nineteen patients had asymptomatic, 34 patients had symptomatic stenoses. All patients had a pre-interventional CT, Doppler and duplex sonography, and digital subtraction angiography (DSA) or magnetic resonance angiography (MRA) prior to the procedural DSA. All patients were offered CEA as the gold-standard procedure and as an alternative to CAS. Both clinical and Duplex sonographical follow-up was obtained at day 1 and 7, month 1, month 3, month 6, month 12, and every subsequent 6 months after the procedure. Mean follow-up time was 22 +/- 1.6 months (+/- SEM).
2/53 patients suffered from stroke. A further 2 patients suffered from carotid artery occlusion shortly after CAS. The cumulative rate of restenosis during follow-up was 24.5 % (13/53). Four of these (7.5 %) were of high-grade and led to further interventional or surgical therapy.
A high rate of restenosis was found during follow-up after CAS. Our analysis of non-selected patients emphasizes that CEA remains the gold-standard procedure for the treatment of symptomatic internal carotid artery stenosis. The frequently performed endovascular treatment of carotid stenosis outside the setting of a randomized controlled trial is not supported by our data.
对于大多数有症状的重度颈内动脉狭窄患者以及特定的重度无症状狭窄患者,颈动脉内膜切除术(CEA)是金标准术式;然而,一部分患者接受颈动脉血管内治疗。我们旨在记录颈动脉支架置入术(CAS)后的中期临床和神经超声检查结果。
53例(平均年龄:65±8岁)重度(经双功超声检查≥70%)颈动脉狭窄患者纳入本研究。19例患者为无症状性狭窄,34例患者为有症状性狭窄。所有患者在进行手术数字减影血管造影(DSA)前均接受了术前CT、多普勒和双功超声检查以及数字减影血管造影(DSA)或磁共振血管造影(MRA)。所有患者均接受CEA作为金标准术式以及作为CAS的替代方案。术后第1天和第7天、第1个月、第3个月、第6个月、第12个月以及此后每6个月进行临床和双功超声随访。平均随访时间为22±1.6个月(±标准误)。
53例患者中有2例发生卒中。另外2例患者在CAS后不久发生颈动脉闭塞。随访期间再狭窄的累积发生率为24.5%(13/53)。其中4例(7.5%)为重度再狭窄,导致进一步的介入或手术治疗。
CAS术后随访期间发现再狭窄率较高。我们对未选择患者的分析强调,CEA仍然是有症状的颈内动脉狭窄治疗的金标准术式。我们的数据不支持在随机对照试验之外频繁进行的颈动脉狭窄血管内治疗。